Treatment of Lower Respiratory Tract Infections

Lower Respiratory Tract Infections (LRTI) Treatment

Aminopenicillins, such as amoxicillin 500-1000 mg every 8 hours, are the first-choice antibiotics for uncomplicated LRTI managed at home, according to the European Respiratory Society 1, 2
Treatment duration should typically be 5-7 days for home-managed LRTI, as recommended by the European Respiratory Society 1, 2
For patients with risk factors for beta-lactamase producing organisms, amoxicillin-clavulanate is recommended by the European Respiratory Society 1
Alternative options for penicillin-allergic patients include macrolides, such as clarithromycin 250-500 mg twice daily, tetracyclines, such as doxycycline 100 mg twice daily, oral cephalosporins for non-anaphylactic penicillin allergy, and third-generation quinolones for treatment failures or complicated cases, as suggested by the European Respiratory Society 1, 2
For patients requiring hospitalization but not ICU care, options include second-generation cephalosporins, such as IV cefuroxime 750-1500 mg every 8 hours, third-generation cephalosporins, such as IV cefotaxime 1 g every 8 hours or IV ceftriaxone 1 g daily, and IV benzyl penicillin 1-4×10^6 units every 2-4 hours or IV amoxicillin 1 g every 6 hours, according to the European Respiratory Society 3
For ICU patients with severe LRTI, combination therapy with a second or third-generation cephalosporin plus either a second-generation quinolone or a macrolide is recommended by the European Respiratory Society 3

Signs of immediate severity, such as temperature <35°C or ≥40°C, heart rate ≥125 beats/min, respiratory rate ≥30 breaths/min, cyanosis, and blood pressure <90/60 mmHg, require hospital referral, as indicated by the European Respiratory Society 1, 4
Other concerning features, such as confusion, drowsiness, altered mental status, chest pain, and suspected complications, also require hospital referral, according to the European Respiratory Society 1, 4
Laboratory and radiological criteria for hospital management include leukopenia, severe leukocytosis, anemia, renal impairment, hypoxemia, hypercapnia, acidosis, coagulation abnormalities, and multilobar involvement on chest radiograph, as recommended by the European Respiratory Society 1, 4

Many LRTIs are viral in origin and self-limiting; antibiotics should only be used when bacterial infection is suspected, as stated by the European Respiratory Society 1, 5
Overuse of fluoroquinolones can lead to resistance; reserve them for treatment failures or complicated cases, according to Praxis Medical Insights 2
Streptococcus pneumoniae is the most common bacterial pathogen in LRTI, and antibiotic therapy should always be active against it, as recommended by the European Respiratory Society 6, 7
Patients should be informed that cough may persist longer than the duration of antibiotic treatment, as indicated by the European Respiratory Society 1

Tetracyclines, such as doxycycline 100 mg twice daily, serve as an alternative first-line option for smokers with LRTI, as recommended by the European Respiratory Society 8
The smoking history itself does not change the initial antibiotic selection unless the patient has developed COPD with exacerbations, according to the European Respiratory Society 8

Fluoroquinolones, such as levofloxacin or moxifloxacin, should be reserved for treatment failures, complicated cases, or when there are clinically relevant bacterial resistance rates against all first-choice agents, as suggested by the European Respiratory Society 8

Antibiotics are indicated only when all three cardinal symptoms are present: increased dyspnea, increased sputum volume, AND increased sputum purulence, as recommended by the European Respiratory Society 8
For severe COPD exacerbations, antibiotics should be considered even with fewer symptoms, according to the European Respiratory Society 8

Advise patients to return if fever persists beyond 48 hours or symptoms persist beyond 3 weeks, as recommended by the European Respiratory Society 8

Consider obtaining a chest X-ray if pneumonia is suspected based on new focal chest signs, dyspnea, tachypnea, or fever lasting more than 4 days, as suggested by the European Respiratory Society 8